Infectious Disease Topics
RSSArticles
-
Infectious Disease Alert Updates
Tuberculosis Transmission From NAAT-negative Patients; Worldwide Rabies Risk: Dogs; Patients Need to Rethink the ‘Quality’ in Healthcare
-
Plazomicin (Zemdri)
Plazomicin is an aminoglycoside recently approved by the Food and Drug Administration for treating complicated urinary tract infections.
-
Here Comes the Sun — And Here Comes Coccidioidomycosis
Another occupational outbreak of coccidioidomycosis in solar farm workers in an endemic area points to the continued risk and the difficulty of preventing such occurrences.
-
In Patients Who Self-catheterize, Antibiotic Prophylaxis Prevents UTIs but Increases Antibiotic Resistance
A randomized, open-label, superiority trial found that daily antibiotic prophylaxis for patients who use clean, intermittent self-catheterization reduced symptomatic urinary tract infections by 48% over a 12-month period. Antibiotic resistance became prevalent in urinary isolates from the group receiving prophylaxis compared to controls.
-
Infectious Disease Alert Updates
Pet Snake Snacks: A Salmonella Treat; Linking HIV-positive Inmates to Outpatient Care
-
Prophylactic Antibiotics for Acute Aspiration
Researchers compared outcomes in patients with aspiration pneumonitis who received prophylactic antibiotics during the first two days after macro-aspiration to patients who received only supportive care during this time. Among the 200 patients meeting the acute aspiration pneumonitis case definition, antimicrobial prophylaxis was not associated with improvement in mortality. However, patients receiving prophylactic antibiotics required more frequent escalation of antibiotics and received more days of antibiotics than those who were managed initially with supportive care alone.
-
Oral Vancomycin Is the Most Cost-effective Treatment for the First Recurrence of Clostridium Difficile Infection
The authors of a pharmacoeconomic study comparing bezlotoxumab plus oral vancomycin, oral vancomycin alone, and fidaxomicin found that oral vancomycin alone was the most cost-effective regimen to treat the first recurrence of Clostridium difficile infection.
-
Infections Associated With Travel to the United States
Infectious illness is common in travelers from other countries visiting the United States. Skin and soft tissue infections, respiratory infections, and gastrointestinal illness are most likely, but specific geographic illnesses such as Lyme disease also occur.
-
IV to Oral Antibiotic Switch for Selected Cases of Endocarditis
Completion of therapy of selected patients with infective endocarditis with orally administered antibiotics is feasible, safe, and effective.
-
Meropenem vs. Piperacillin-tazobactam for Bacteremia Due to ESBL-Producers: The MERINO Trial
In an open-label, randomized, noninferiority trial evaluating the efficacy of piperacillin-tazobactam vs. meropenem for definitive therapy in treating bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae, piperacillin-tazobactam therapy did not result in noninferior 30-day, all-cause mortality compared to meropenem. Investigators stopped the trial early due to futility.